A randomised feasibility study of extended chemotherapy with neoadjuvant carboplatin, then surgery followed by adjuvant paclitaxel and gemcitabine versus neoadjuvant gemcitabine and carboplatin, then surgery, followed by adjuvant paclitaxel for women with epithelial non-mucinous advanced inoperable peritoneal malignancy.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin (Primary) ; Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Acronyms NEO-ESCAPE
- 17 Sep 2013 Biomarkers information updated
- 01 Jun 2012 Primary endpoint 'Target-achievement-rate' has been met in patients receiving C-PG but not CG-P.
- 12 Jul 2011 Planned end date added 6 Aug 2013 as reported by EudraCT.